Abstract: This disclosure relates to bioactive fluid compositions and methods of using the compositions. The bioactive fluid compositions can be used for intravenous administration in place of conventional crystalloid fluid compositions.
Type:
Grant
Filed:
March 21, 2024
Date of Patent:
September 23, 2025
Assignee:
GanD, Inc.
Inventors:
Douglas Tadaki, David Steed, Peta J. O'Connell